SEC Filing Summary: Kindly MD, Inc. (NAKA)
Business Context and Reporting Period
This Form 8-K was filed by Kindly MD, Inc. on November 19, 2025. The filing serves to announce the Company's financial results for the fiscal quarter ended September 30, 2025. The Company is an emerging growth company headquartered in Salt Lake City, Utah, with common stock trading on The Nasdaq Stock Market LLC under the symbol "NAKA" and warrants trading on the OTC Pink Market under "NAKAW."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details has been issued, but the specific figures are not included in the body of this 8-K form.
Material Changes
No material changes versus the prior comparable period are detailed in this filing text. The document references an attached press release (Exhibit 99.1) for the actual results but does not summarize the variances or trends within the 8-K itself.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other registration statements.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for actual revenue, net income, and cash flow figures for the quarter ended September 30, 2025.
- Verify the trading status and volume of the Common Stock (NAKA) and Warrants (NAKAW) following the announcement.
- Confirm the Company's status as an emerging growth company and any implications for financial reporting standards.
- Check for any subsequent filings that may incorporate the press release details by reference.